Following this educational activity, learners will be able to:

CLINICAL EVALUATION OF PATIENTS

• Identify the strengths and limitations of breast cancer imaging modalities such as MRI and PET/CT scanning in early diagnosis through state IV or recurrent disease. 
• Select patients for whom PET/CT imaging may be an appropriate supplement to standard imaging in the staging of disease.
• Interpret and use nationally recognized quality control recommendations on ER/PR and HER-2 testing in breast cancer patients.

MANAGEMENT OF EARLY STAGE DISEASE

• Evaluate the duration of endocrine therapy in the adjuvant setting and the choice of endocrine therapy in the metastatic setting for patients with hormone receptor positive disease.
• List the benefits and risks of adjuvant chemotherapy regimens used in various breast cancer subtypes and the role of gene-based assays in determining the need for chemotherapy.
• Identify patients likely to benefit from oral chemotherapy and provide education and assessment of compliance to ensure maximum clinical benefit.

MAKING EVIDENCE-BASED TREATMENT DECISIONS IN ADVANCED BREAST CANCER

• Describe the management of long term bone health in patients undergoing prolonged endocrine therapy.
• Summarize the considerations in the use of hormonal or cytotoxic therapy with or without targeted therapy and use of single agent versus combination therapy.
• Assess available evidence to evaluate toxicity and efectiveness of therapy in patients with metastatic disease.